General
Preferred name
ASPARTIC ACID
Synonyms
L-aspartic acid ()
Asparagic acid ()
Aspatofort ()
[3H]L-aspartic acid ()
Aspartic acid, l- ()
Aspartic acid,l ()
FEMA NO. 3656 ()
Acido aspartico ()
NSC-3973 ()
Acide aspartique ()
Deamidated asparagine ()
Aspartate ()
P&D ID
PD002813
CAS
56-84-8
27881-03-4
39162-75-9
181119-33-5
155436-59-2
Tags
available
drug
Approved by
FDA
Drug Status
approved
investigational
nutraceutical
Max Phase
3.0
Drug indication
Amino Acid
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Endogenous excitatory amino acid neurotransmitter
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
19
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
72
Molecular Weight
133.04
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
3
Ring Count
0
Aromatic Ring Count
0
cLogP
-1.13
TPSA
100.62
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
0.0
QED
0.45
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13
Endogenous Metabolite
MOA
metallic radical formation stimulant
Pathway
Metabolic Enzyme/Protease
Source data
